This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Need cash fast? Explore various ways to get instant cash from home and improve your financial situation today.
20,693 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Upstart has stunned the market with a renewed focus on AI-powered lending, but questions remain. This article breaks ...
For the next 10 years, dividend stocks hold next potential with steady income and growth. Discover four dependable na...
As the space economy matures, investors face a clear choice between Redwire and Rocket Lab. This guide breaks down bu...
Realty Income just announced a $1 billion joint venture with Apollo, expanding its real estate platform and preservin...
In a volatile market, CVS Health leads a retirement-focused view of the magic formula, topping Qualcomm and Valero as...
Gold Exposure through the SPDR Gold ETF can anchor a diversified portfolio. This article explains why SPDR Gold Been ...
Lemonade is doubling down on artificial intelligence to reshape insurance. This piece breaks down what lemonade betti...
A blunt six-word warning from a top hedge fund founder has traders and investors rethinking AI hype. This article bre...
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
When celebrities face defamation fights, money matters follow close behind. This look at Tyra Banks, Netflix, and the...
As Amazon prepares for its next earnings release, a provocative scenario targets Andy Jassy and AWS. This piece break...